Protagonist Therapeutics (PTGX) Q2 2026 Earnings

May 5Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.63
-0.4
-0.18
0.05

Details

Expected EPS
-0.500389
Actual EPS
0.05
Surprise EPS
0.55
Surprise Percent
+109.99%

Description

⁨Protagonist Therapeutics⁩ (⁦PTGX⁩) has reported earnings of ⁦0.05⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts